Results 231 to 240 of about 375,973 (338)

Correlation between Subjective and Objective Parameters of Nasal Polyps

, 2009
Valérie Hox, Ina Callebaut, Ellen Dillissen, Jan Ceuppens, Peter W. Hellings   +4 more
openalex   +1 more source

Factor Analysis‐Based Quantitative Endotyping Improves Associations With CRS Cross‐Sectional and Longitudinal Outcomes

International Forum of Allergy &Rhinology, Volume 16, Issue 1, Page 32-42, January 2026.
ABSTRACT Background Chronic rhinosinusitis (CRS) is a heterogeneous inflammatory disease characterized by persistent sinonasal inflammation. There is increasing interest in endotype‐based classification, which categorizes CRS based on underlying inflammatory pathways.
Brooke N. Gleason, Zhidi Luo, Aditi Agarwal, Siyuan Dong, Regan L. Harmon, Junqin Bai, Chun‐Kang Liao, Julia Huang, David B. Conley, Kevin C. Welch, Robert C. Kern, Stephanie S. Smith, Anju T. Peters, Whitney S. Stevens, Atsushi Kato, Lutfiyya N. Muhammad, Bruce K. Tan   +16 more
wiley   +1 more source

Prioritization of nasal polyp-associated genes by integrating GWAS and eQTL summary data. [PDF]

Front Genet, 2023
Yoshikawa M, Asaba K, Nakayama T.
europepmc   +1 more source

Anti-Inflammatory and Anti-Fibrotic Activities of Nocardiopsis sp. 13G027 in Lipopolysaccharides- Induced RAW 264.7 Macrophages and Transforming Growth Factor Beta-1-Stimulated Nasal Polyp-Derived Fibroblasts

, 2021
Grace Choi, Geum Jin Kim, Hyukjae Choi, Il‐Whan Choi, Dae-Sung Lee   +4 more
openalex   +2 more sources

Patient‐Specific Coculture of S. aureus and P. aeruginosa Enhances Epithelial Barrier Disruption and Virulence in CRS

International Forum of Allergy &Rhinology, Volume 16, Issue 1, Page 43-54, January 2026.
ABSTRACT Background Chronic rhinosinusitis (CRS) is a chronic inflammatory disease that is associated with polymicrobial infections, often involving S. aureus and P. aeruginosa. It is unclear whether the polymicrobial context plays a role in exacerbating epithelial damage, inflammation, and resistance to therapy. Methods S. aureus and P. aeruginosa (n =
Xiaohan Sun MMed, Mahnaz Ramezanpour, Jordan Hall, Emma Barry, Alkis J. Psaltis, Peter‐John Wormald, Sarah Vreugde   +6 more
wiley   +1 more source

One-year efficacy of Dupilumab in sense of smell, nasal polyp score and quality of life in CRSwNP patients: A real-world multicenter study in Brazil. [PDF]

Braz J Otorhinolaryngol
Mieli OM, Valera FCP, Dinarte VRP, de Lima CMF, Nakanishi M, Zanetti MET, Pires FO, Garcia DM, Murashima AAB, Arruda LKP, Romano FR, Lemos JES, Kosugi EM, Sakano E, Tepedino MS, Tamashiro E, Anselmo-Lima WT.   +16 more
europepmc   +1 more source

Upregulation of Platelet-Activating Factor Receptor Expression and Lyso-Platelet-Activating Factor Isoforms in Human Nasal Polyp Tissues. [PDF]

J Clin Med, 2023
Roca-Ferrer J, Pérez-González M, Alobid I, Tubita V, Fuentes M, Bantulà M, Muñoz-Cano R, Valero A, Izquierdo I, Mullol J.   +9 more
europepmc   +1 more source

Guideline for the use of immunobiologicals in chronic rhinosinusitis with nasal polyps (CRSwNP) in Brazil

, 2022
Fabiana Cardoso Pereira Valera
openalex   +1 more source

IL-17A as a regulator of neutrophil survival in nasal polyp disease of patients with and without cystic fibrosis [PDF]

, 2011
Lara Derycke, Nan Zhang, Gabriële Holtappels, Tineke Dutré, C. Bachert   +4 more
openalex   +1 more source

Real‐World Treatment Patterns in AERD: An Analysis of ATAD, Biologics, and Combination Therapy

International Forum of Allergy &Rhinology, Volume 16, Issue 1, Page 99-101, January 2026.
Key Points Contemporary aspirin exacerbated respiratory disorder (AERD) therapy commonly includes aspirin desensitization (55%) and biologics (48%). Aspirin desensitization therapy has higher discontinuation rates than biologics. Patients receiving biologics are younger, and ∼25% of the patients switch to other agents.
Nitish Kumar, Tyson Pace, Pedro Lança Gomes, Michael J. Marino, Amar Miglani, Devyani Lal   +5 more
wiley   +1 more source